PEKMEZ, M. Et Al. 2025. Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis. MEDICAL ONCOLOGY , vol.42, no.5 .

PEKMEZ, M., Mete, S. B., Aksut, Y., Ogutcu, I., BAŞTÜRK, F. N., GERÇEK, Y. C., ... Sengelen, A.(2025). Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis. MEDICAL ONCOLOGY , vol.42, no.5.

PEKMEZ, Murat Et Al. "Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis," MEDICAL ONCOLOGY , vol.42, no.5, 2025

PEKMEZ, Murat Et Al. "Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis." MEDICAL ONCOLOGY , vol.42, no.5, 2025

PEKMEZ, M. Et Al. (2025) . "Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis." MEDICAL ONCOLOGY , vol.42, no.5.

@article{article, author={Murat PEKMEZ Et Al. }, title={Fatty acid synthase inhibitor cerulenin attenuates glioblastoma progression by reducing EMT and stemness phenotypes, inducing oxidative and ER stress response, and targeting PI3K/AKT/NF-κB axis}, journal={MEDICAL ONCOLOGY}, year=2025}